INSULIN RESISTANCE, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
3
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
Decreased waist to hip ratio
|
phenotype |
|
Finding
|
28
|
|
0.100 |
None |
|
0 |
|
|
|
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.400 |
None |
1.000 |
1 |
|
2000 |
2000 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.310 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
399
|
27
|
0.310 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hodgkin lymphoma, lymphocyte depletion
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malignant tumor of mediastinum
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Nodular Lymphocyte Predominant Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
51
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mediastinal Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
9
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mixed Cellularity Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
19
|
3
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphocyte Rich Classical Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Compensatory Hyperinsulinemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
30
|
2
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Exogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Endogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Rett Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
234
|
368
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
338
|
456
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Muscular Dystrophy, Duchenne
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
375
|
170
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Thyroid Neoplasm
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1164
|
135
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
synovial sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
299
|
4
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |